Inhaled thiamphenicol and acetilcysteine in children with acute bacterial rhinopharyngitis

International Journal of Immunopathology and Pharmacology

Volumn 21, Issue 3, 2008, Pages 625-629

  Varricchio, A ^a   Capasso, M ^b   di Gioacchino, M ^c   Ciprandi, Giorgio ^d  

^a San Gennaro Hospital   (Italy)

^b Piedimonte Matese Hospital   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Antibiotic therapy; Inhaling device; Rhinopharyngitis

Indexed keywords

ACETYLCYSTEINE; SODIUM CHLORIDE; THIAMPHENICOL;

AEROSOL; ARTICLE; BACTERIAL RHINOPHARYNGITIS; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; FEVER; FIBERSCOPE ENDOSCOPY; HUMAN; HUMAN TISSUE; INHALER; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NEBULIZER; NOSE OBSTRUCTION; NOSE SMEAR; PATIENT COMPLIANCE; PHARYNX DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RHINORRHEA; SINGLE BLIND PROCEDURE; SORE THROAT; UNSPECIFIED SIDE EFFECT; ACUTE DISEASE; CHILD; INHALATIONAL DRUG ADMINISTRATION; PHARYNGITIS; RHINITIS;

ACETYLCYSTEINE; ACUTE DISEASE; ADMINISTRATION, INHALATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PHARYNGITIS; RHINITIS; SINGLE-BLIND METHOD; THIAMPHENICOL;

EID: 53749106586     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200802100316     Document Type: Article

References (16)

1. White CB, Foshee WS. Upper respiratory tract infections in adolescents. Adolesc Med 2000; 11: 225-31.
2. Ovchinnikov Ain. Rhinopharyngitis as one of clinical manifestations of acute respiratory virus infection. Modern view on the problem. Ter Arkh 2006; 78: 57-63.
3. Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA 1998; 279:875-9.
4. Caramia G, Ruffini E. The use and abuse of antibiotics in childhood. Pediatr Med Chir 2002; 24:194-9.
5. Karlidaǧ T, Demirdaǧ K, Kaygusuz I, et al. Resistant bacteria in the adenoid tissues of children with otitis media with effusion. Int J Pediatr Otorhinolaryngol 2002; 64:35-40.
6. Bernstein JM, Haase E, Scannapieco F, et al. Bacterial interference of penicillin-sensitive and -resistant Streptococcus pneumoniae by Streptococcus oralis in an adenoid organ culture: implications for the treatment of recurrent upper respiratory tract infections in children and adults. Ann Otol Rbinol Laryngol 2006; 115:350-5.
7. Hasan MA, Lange CF. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics. J Aerosol Med 2007; 20:282-7.
8. Pilcer G, Goole J, Van Gansbeke B, et al. Pharmacoscintigraphic and pharmacokinetic evaluation of tobramycin DPI formulations in cystic fibrosis patients. Eur J Pharm Biopharm 2007; 68: 413-21-8.
9. Gibson RL, Emerson J, Mayer-Hamblett N, et al. Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatr Pulmonol 2007; 42:610-5.
10. Chuchalin A, Csiszer E, Gyurkovics K, et al. A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. Paediatr Drugs 2007; 42:307-42.
11. Padman R, McColley SA, Miller DP, et al. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007; 119:531-8.
12. Clavel A, Boulamery A, Bosdure E, et al. Nebulisers comparison with inhaled tobramycin in young children with cystic fibrosis. J Cyst Fibros 2007; 6: 137-42.
13. Varricchio A, Tricarico D, De Lucia A, et al. Inhaled tobramycin in children with acute bacterial rhinopharyngitis. Int J Immunopathol Pharmacol 2006; 19:131-6.
14. Wang DY, Clement PAR, Kaufman L, Derde MP. Chronic nasal obstruction in children. A fiberscopic study. Rhinology 1995; 33:4-9.
15. Immergluck LC. Community-associated infections in children - update on community-associated methicillin-resistant Staphylococcus aureus for the practitioner. Ethn Dis 2007; 17(S):2-9.
16. Switala M, Hrynyk R, Smutkiewicz A, et al. Pharmacokinetics of florfenicol, thiamphenicol, and chloramphenicol in turkeys. J Vet Pharmacol Ther 2007; 30:145-50.